Skip to main content

Peer Review reports

From: Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects

Original Submission
17 Jun 2019 Submitted Original manuscript
15 Sep 2019 Author responded Author comments - Cristobal Ramírez-Sevilla
20 Jul 2019 Reviewed Reviewer Report - Yibeltal Aschale
17 Aug 2019 Reviewed Reviewer Report - Alberto Alape-Girón
Resubmission - Version 2
15 Sep 2019 Submitted Manuscript version 2
1 Oct 2019 Author responded Author comments - Cristobal Ramírez-Sevilla
25 Sep 2019 Reviewed Reviewer Report - Yibeltal Aschale
19 Sep 2019 Reviewed Reviewer Report - Alberto Alape-Girón
Resubmission - Version 3
1 Oct 2019 Submitted Manuscript version 3
3 Oct 2019 Author responded Author comments - Cristobal Ramírez-Sevilla
Resubmission - Version 4
3 Oct 2019 Submitted Manuscript version 4
Publishing
9 Oct 2019 Editorially accepted
28 Oct 2019 Article published 10.1186/s12879-019-4541-y

You can find further information about peer review here.

Back to article page